Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.
about
Oridonin, a Promising ent-Kaurane Diterpenoid Lead CompoundDiscovery and development of natural product oridonin-inspired anticancer agentsSTAT3 Inhibition Suppresses Hepatic Stellate Cell Fibrogenesis: HJC0123, a Potential Therapeutic Agent for Liver Fibrosis.Design and synthesis of novel oridonin analogues as potent anticancer agents.
P2860
Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.
@ast
Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.
@en
type
label
Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.
@ast
Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.
@en
prefLabel
Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.
@ast
Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.
@en
P2093
P2860
P1476
Enhanced effects of novel oridonin analog CYD0682 for hepatic fibrosis.
@en
P2093
Brittany M Graham
Chunyong Ding
Cristiana Rastellini
Fredrick J Bohanon
Geetha L Radhakrishnan
Ravi S Radhakrishnan
Xiaofu Wang
P2860
P304
P356
10.1016/J.JSS.2015.07.042
P577
2015-08-05T00:00:00Z